Northwest Capital Management’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.6K | Hold |
3,397
| – | – | 0.01% | 250 |
|
|
2025
Q1 | $10.8K | Hold |
3,397
| – | – | ﹤0.01% | 311 |
|
|
2024
Q4 | $18.2K | Hold |
3,397
| – | – | 0.01% | 263 |
|
|
2024
Q3 | $17.9K | Hold |
3,397
| – | – | 0.01% | 269 |
|
|
2024
Q2 | $6.18K | Hold |
3,397
| – | – | ﹤0.01% | 345 |
|
|
2024
Q1 | $6.05K | Hold |
3,397
| – | – | ﹤0.01% | 430 |
|
|
2023
Q4 | $5.98K | Hold |
3,397
| – | – | ﹤0.01% | 424 |
|
|
2023
Q3 | $4.96K | Hold |
3,397
| – | – | ﹤0.01% | 424 |
|
|
2023
Q2 | $7.78K | Buy |
+3,397
| New | +$7.78K | ﹤0.01% | 400 |
|